Andere talen Veloxis Pharmaceuticals A/S

Aandelen

VELO

DK0060048148

Vertraagde tijd Nasdaq Copenhagen Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^DKK	-.--%		-.--%	-0,50%

2022	Veloxis Pharmaceuticals kondigt de toediening aan van de eerste patiënt door partner Xenikos in de wereldwijde Fase 3-studie ter evaluatie van T-Guard(R) bij patiënten met therapieresistente acute graft-versus-host-ziekte (SR-aGVHD)	CI
2019	Transcript : Asahi Kasei Pharma Denmark A/S, Veloxis Pharmaceuticals A/S - M&A Call

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)	28-06-22
Scandion Oncology A/S : appoints Johnny Stilou as new CFO	02-06-21
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.	26-04-21
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020	17-02-20
Veloxis Pharmaceuticals A/S Announces Board Appointments	17-02-20
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index	07-02-20
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index	30-01-20
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index	30-01-20
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S	29-01-20
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting	27-01-20
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S	27-01-20
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications	27-01-20
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting	24-01-20
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen	24-01-20
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S	24-01-20
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications	24-01-20
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer	23-01-20
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer	20-01-20
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer	17-01-20
Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto	16-01-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Veloxis Pharmaceuticals A/S

Aandelen

VELO

DK0060048148

Andere talen

Filters